MedPharm offers fully scalable, GMP-certified manufacturing solutions to ensure consistent, high-quality topical and transdermal formulations production. We support pharmaceutical companies from the final stages of drug development to full-scale commercial supply by utilizing advanced production technologies, strict quality control measures, and regulatory-compliant processes.
Whether you require large-scale production, specialized compounding, customized packaging, or dedicated facilities for highly potent and hormone-based products, MedPharm provides a flexible and efficient manufacturing platform tailored to meet your specific product and market needs.
MedPharm leverages state-of-the-art manufacturing capabilities enforces regulatory-driven quality assurance and offers flexible production solutions to ensure that your topical and transdermal drug products are manufactured to the highest standards for global market success.
Learn more about our Commercial Production Capabilities below.
Full-scale production of topical and transdermal drug formulations GMP-compliant, FDA- and EMA-approved manufacturing facilities Robust process validation and quality control for market-ready products
Precision-based compounding for uniform formulation consistency Automated, high-efficiency emulsification and homogenization Capability to handle various semi-solid and liquid formulations
Full-scale production of topical and transdermal drug formulations GMP-compliant, FDA- and EMA-approved manufacturing facilities Robust process validation and quality control for market-ready products
Dedicated high-containment manufacturing for potent and hormone-based drugs GMP-certified cleanroom facilities with advanced air handling systems Strict control of occupational exposure limits (OEL) and worker safety measures
In-house quality control (QC) testing for batch release and compliance Analytical and bioanalytical testing for potency, stability, and purity Regulatory-compliant data management and validation protocols
Flexible production capabilities for orphan drugs and niche formulations Custom batch sizes for low-volume, high-value pharmaceuticals Scalable solutions for transitioning from clinical to commercial supply